CagriSema (5mg)
Amylin/GLP-1 Dual-Pathway Research Formulation
Order CagriSema (5mg) online for laboratory research with US shipping options at checkout. Compare the listed vial options and current price, then add your selection to cart and continue to checkout. Review available COA records for the exact product, strength and lot. Research Use Only; not for human or veterinary use.
Browse GLP-1 & Metabolic listings
CagriSema (Cagrilintide + Semaglutide) is listed for glp-1 & metabolic laboratory research. Catalog vial contents are 5mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
Buy CagriSema (Cagrilintide + Semaglutide) online with US shipping
Paid, in-stock orders placed before 1:00 PM Central Time on business days are scheduled to ship the same day.
Standard domestic delivery generally takes 2–5 business days after dispatch, not after placing the order.
Enter your full shipping address at checkout to confirm available shipping methods and cost. Delivery varies by ZIP code and carrier; weekends, holidays and carrier delays can affect arrival. These are online shipping destinations, not local stores or pickup locations.
CagriSema (Cagrilintide + Semaglutide) shipping to New York, NY
Ordering for a research address in New York? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
CagriSema (Cagrilintide + Semaglutide) shipping to Los Angeles, CA
Ordering for a research address in Los Angeles? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
CagriSema (Cagrilintide + Semaglutide) shipping to Chicago, IL
Ordering for a research address in Chicago? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
CagriSema (Cagrilintide + Semaglutide) shipping to Houston, TX
Ordering for a research address in Houston? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
CagriSema (Cagrilintide + Semaglutide) shipping to Phoenix, AZ
Ordering for a research address in Phoenix? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
CagriSema (Cagrilintide + Semaglutide) shipping to Miami, FL
Ordering for a research address in Miami? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
CagriSema (Cagrilintide + Semaglutide) shipping to Atlanta, GA
Ordering for a research address in Atlanta? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
CagriSema (Cagrilintide + Semaglutide) shipping to Seattle, WA
Ordering for a research address in Seattle? Select your vial strength above, review its available analysis records, then choose Buy Now. Shipping options and cost are confirmed for your address at checkout; the standard domestic estimate is not a city-specific arrival guarantee.
Research Applications & Benefits
- Cagrilintide + Semaglutide formulation
- Amylin and GLP-1 pathway research
- Metabolic signaling models
- Lyophilized research reagent
What is CagriSema (Cagrilintide + Semaglutide)?
CagriSema is a catalog blend of cagrilintide and semaglutide. Cagrilintide is an amylin analogue; semaglutide acts at GLP-1 receptors. The listed 5mg is total vial content, not confirmed individual component amounts.
Listed vial contents: 5mg. These are supplied quantities, not administration doses. Current pricing and availability are shown in the strength selector.
Which identity should I verify?
The component ratio remains unconfirmed. A trial of coadministered clinical preparations does not establish the composition, stability or equivalence of a premixed research vial. Match each component's identity and amount to original lot analysis.
What mechanisms are being studied?
The two components address distinct hormone pathways. Combination studies examine whether the observed response differs from each constituent. Complementary pathways alone do not prove synergy in this supplied mixture.
What are the research questions?
- Amylin and GLP-1 pathway comparisons
- Combination versus constituent experiments
- Mixture identity, component content and stability
What does the published work describe?
Garvey and colleagues' 2025 REDEFINE 1 trial compared coadministered cagrilintide and semaglutide with the individual agents and placebo over 68 weeks. It studied adults with overweight or obesity without diabetes. These controlled clinical comparisons do not validate this commercial premixed vial.
Experimental models in the cited papers
- REDEFINE 1: randomized, double-blind phase 3a human combination trial
What could future research explore?
Laboratory research can characterize component identity and mixture stability before comparing pathway responses. Future therapeutic combinations need evidence for the actual formulation rather than an assumption that all mixtures are equivalent.
These are research directions, not established applications of the product sold here.
What are the limits of this evidence?
Component findings and clinical coadministration studies do not establish the safety, stability or efficacy of this laboratory blend. Clinical findings apply to the tested formulation, trial population and study conditions. They do not establish the identity, safety or effectiveness of this laboratory vial. Research Use Only: this material is not a finished medicine.
Study references
- Garvey WT, et al. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2025. PMID 40544433
How should I check lot documentation?
Match the product, strength and lot to an original analysis document. Literature describes experimental findings; it does not verify the contents of this inventory. A report is evidence only for the product, strength and lot it names.
How is CagriSema (Cagrilintide + Semaglutide) handled in the lab?
For CagriSema (Cagrilintide + Semaglutide), record the product code CAGRISEMA-5, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
For CagriSema (Cagrilintide + Semaglutide), verify each component and its documented amount before choosing a common solvent. Components may dissolve or precipitate differently as pH changes. Check the whole mixture in a small-scale compatibility study; clarity alone does not prove that every component is present at the intended concentration.
5mg describes the listed total vial contents of CagriSema (Cagrilintide + Semaglutide), not the amount of each ingredient. Calculate each component's mass concentration separately only when its amount is documented. Do not assign the mixture a single molecular weight or calculate a single peptide molarity from its total mass.
Use the documented storage conditions for the supplied CagriSema (Cagrilintide + Semaglutide) form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
A CagriSema (Cagrilintide + Semaglutide) laboratory protocol should record identity, product code CAGRISEMA-5, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Research Use Only. Not for human consumption, therapeutic, veterinary or any in-vivo use.
Product Specifications
- Compound
- CagriSema (Cagrilintide + Semaglutide)
- CAS Number
- Mixture
- Molecular Weight
- Mixture
- HPLC Purity Specification
- ≥99% each
- Category
- GLP-1 & Metabolic
- Starting Price
- $109.00 USD
- Country of Origin
- United States
- Shipping
- Cold-chain insulated packaging, fast domestic delivery
- Payment
- Card, ACH, and cryptocurrency (10% discount)
Quality & Verification
CagriSema (Cagrilintide + Semaglutide) has a catalog purity specification of ≥99% each; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use. For a blend, an overall chromatographic percentage does not establish each component's identity or amount.
Frequently Asked Questions
What is CagriSema (Cagrilintide + Semaglutide)?
CagriSema (Cagrilintide + Semaglutide) is listed for glp-1 & metabolic laboratory research. Catalog vial contents are 5mg; select the required strength before ordering. This material is supplied for Research Use Only, not as a medicine or a product for human or veterinary use.
What strengths of CagriSema (Cagrilintide + Semaglutide) are available?
The catalog lists 5mg. These labels describe vial contents, not administration doses. Select the required strength for current pricing and availability; match analysis records to that exact strength and lot.
How should I interpret CagriSema (Cagrilintide + Semaglutide) purity results?
CagriSema (Cagrilintide + Semaglutide) has a catalog purity specification of ≥99% each; this is not a measured result for every vial. Match the product, exact strength, batch and lot to its analysis record and read only the reported fields. HPLC peak-area purity, measured content and endotoxin are separate measurements. A blank field means no result is reported, not zero or passed. A purity percentage alone does not establish identity, sterility or suitability for human use. For a blend, an overall chromatographic percentage does not establish each component's identity or amount.
How should CagriSema (Cagrilintide + Semaglutide) be handled in the laboratory?
For CagriSema (Cagrilintide + Semaglutide), record the product code CAGRISEMA-5, selected strength and lot before opening. Follow the material-specific safety data sheet and laboratory SOP, with appropriate gloves, eye protection and containment. For a documented dry preparation, let the sealed vial equilibrate before opening to reduce condensation; minimize time open and use clean, compatible vessels.
How do I choose a laboratory solvent for CagriSema (Cagrilintide + Semaglutide)?
For CagriSema (Cagrilintide + Semaglutide), verify each component and its documented amount before choosing a common solvent. Components may dissolve or precipitate differently as pH changes. Check the whole mixture in a small-scale compatibility study; clarity alone does not prove that every component is present at the intended concentration.
How do I calculate a CagriSema (Cagrilintide + Semaglutide) stock concentration?
5mg describes the listed total vial contents of CagriSema (Cagrilintide + Semaglutide), not the amount of each ingredient. Calculate each component's mass concentration separately only when its amount is documented. Do not assign the mixture a single molecular weight or calculate a single peptide molarity from its total mass.
How should CagriSema (Cagrilintide + Semaglutide) be stored after preparation?
Use the documented storage conditions for the supplied CagriSema (Cagrilintide + Semaglutide) form and lot. For a documented lyophilized preparation, keep the vial sealed and protected from moisture; for solutions, validate temperature, light exposure and holding time in the assay. Use compatible single-use aliquots when appropriate to reduce repeated freeze-thaw. No universal temperature or 28-day solution shelf life is established by the catalog name.
What should a CagriSema (Cagrilintide + Semaglutide) lab protocol document?
A CagriSema (Cagrilintide + Semaglutide) laboratory protocol should record identity, product code CAGRISEMA-5, strength, lot, applicable analysis results, solvent and pH, stock concentration, dilution sequence, vessel type, storage history and assay endpoints. Include vehicle and reference controls, independent replicates and predefined acceptance criteria. Separate handling validation from biological interpretation; these notes do not provide administration or dosing instructions.
Does Fmoc or Boc synthesis explain this CagriSema (Cagrilintide + Semaglutide) product?
CagriSema (Cagrilintide + Semaglutide) is a catalog combination, not a single peptide sequence. Fmoc/Boc terminology can describe an individual component's synthesis only when documented; it does not establish the blend ratio, component identity or composition of this lot.
Is CagriSema (Cagrilintide + Semaglutide) for human use?
No. CagriSema (Cagrilintide + Semaglutide) is strictly Research Use Only. It is not intended for human or veterinary use, diagnosis or treatment. Laboratory handling guidance is not an administration protocol.
Research Use Only. This product is intended for licensed laboratory research and is not for human or veterinary use.
